donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Medical Disorders
Resources
Basic InformationLookupsLatest News
Do Immune-Based Cancer Drugs Work Better in Men?Gene Found in Amish Helps Protect Their HeartsOmicron May Overcome Prior COVID InfectionWindy Days Are Safer Days When It Comes to COVID-19Most Vaccinated Adults Plan to Get Boosters: PollStudy Finds Delta Somewhat Resistant to Vaccines — What About Omicron?Is the Mumps Vaccine Becoming Less Effective?Vaping Can Trigger Gene Changes in Cells: StudyPfizer or Moderna? Head-to-Head Study Shows One Shot Has an EdgeSurvivors of Severe COVID Face Doubled Risk for Death a Year LaterNearly 7% of U.S. Kids Have Had a Head Injury or ConcussionFirst U.S. Omicron Case Reported in CaliforniaCDC to Toughen COVID Testing for International TravelersCertain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryFDA Panel Gives Support to Merck's COVID Antiviral PillLong-Haul COVID Can Include Chronic Fatigue: StudyVaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: FauciPfizer to Seek FDA Approval of Boosters for Teens Ages 16-17Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron VariantCOVID May Trigger Heart Condition in Young AthletesMany People With High Blood Pressure May Take a Drug That Worsens It: StudyBiden Pushes Vaccines, Masks as Best Defense Against Omicron VariantHow Easily Can Singing Spread COVID-19?New Insights Into What Might Drive Parkinson's DiseaseHot Days Can Send Even Younger Folks to the ERMerck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDAVaccine Makers Already Testing Their Shots Against Omicron VariantWhat Experts Know About the Omicron 'Variant of Concern'What You Need to Know About Stomach CancerFetal Infection With COVID-19 Possible, But UnlikelyRural Hospitals' ERs Just as Effective as Urban Ones: StudyBoosters: What You Need to KnowAHA News: Pulmonary Embolism Is Common and Can Be Deadly, But Few Know the SignsAlmost 1 in Every 3 College-Age Americans Are Now ObeseAnimal Study Offers Hope for a Vaccine Against Lyme DiseaseAddictive Opioid Painkillers Might Not Be Needed After Knee SurgeryYears of Blood Thinners After Stenting Might Not Be NecessaryU.S. COVID Cases, Hospitalizations on the Rise Just Before ThanksgivingVaping Could Weaken Your Bones, Study FindsWearable Vibration Device May Ease Parkinson's TremorPfizer Says Its COVID Vaccine Provides Full Protection to AdolescentsBooster Shots Prompt Stronger, Longer Protection Than Original Shots: StudyTV Remotes, Nurse Call Buttons: Where Coronavirus Lingers in Nursing HomesBlood Pressure During Surgery May Be Crucial After Spinal Cord InjuryPeople on Immune-Suppressing Meds Fare Equally Well With Severe COVIDDelta Variant Ups Risk of Stillbirth, Death During Pregnancy, Reports ShowAre You at Risk for Stress Urinary Incontinence?AHA News: Getting Better Overall Sleep Might Be the Key to Better HealthCDC Panel Backs Pfizer, Moderna Boosters for All AdultsNeurologists' Group Issues New Treatment Guidelines for Early Parkinson's
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Access to Top Drugs Makes the Difference for Black Lung Cancer Patients

HealthDay News
by Robert Preidt
Updated: Oct 12th 2021

new article illustration

TUESDAY, Oct. 12, 2021 (HealthDay News) -- Equal access to the most effective drugs helps eliminate the survival disparity between Black and white lung cancer patients in the United States, a new study shows.

In general, Black lung cancer patients are more likely to die than white patients, but these findings suggest that barriers to care are the main cause of racial disparities in lung cancer survival rates, the researchers said.

They used the National Cancer Database to analyze outcomes among more than 3,000 patients who were diagnosed with advanced lung cancer between 2015 and 2016 and received immunotherapy.

The death rate among Black patients was 15% lower than for whites, according to the study presented recently at an American Association for Cancer Research meeting.

"It is quite clear that if people have access to treatment, they have better survival," said study leader Tomi Akinyemiju, an associate professor in Duke University's Department of Population Health Sciences.

"The question that follows is why are some not accessing health care? It's not just about having insurance, which does help people afford treatment, but there are other important factors getting in the way," she said in a university news release.

Six in 10 of the patients in the study had government insurance, and nearly one-third lived in zip codes with the highest incomes. But only 16% of Black patients lived in the highest income areas.

Black patients in the study were more likely to be younger at diagnosis and to be treated at an academic cancer facility, factors which could be associated with improved outcomes, according to the researchers.

Median time from diagnosis to death was 9.13 months for white patients and 9.49 months for Black patients.

"Our study demonstrates that if we could wave a magic wand so that everyone receives the best treatment, we would see racial disparities in lung cancer outcomes eliminated," Akinyemiju said. "Black patients do well after immunotherapy, so that makes our original question more urgent: Why are they less likely to receive immunotherapy and how do we design interventions to address those barriers?"

Research presented at meetings should be considered preliminary until published in a peer-reviewed journal.

More information

The American Cancer Society has more on lung cancer.

SOURCE: Duke University, news release, Oct. 6, 2021